Active	Status	Sponsor type	Region	Phase	Filter
19 Active 9 Inactive 28 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Poli, Sven
ESCAPE-NEXT, NCT04462536 / 2020-002360-30: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis	Completed	3	850	Europe, Canada, US, RoW	Placebo, Nerinetide, NA-1	NoNO Inc., University of Calgary	Stroke, Acute	08/23	08/23
FASTEST, NCT03496883: Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial	Recruiting	3	860	Europe, Canada, Japan, US	Recombinant Activated Factor VII (rFVIIa), NovoSeven, NiaStase, Placebo	Joseph Broderick, MD, Novo Nordisk A/S, National Institute of Neurological Disorders and Stroke (NINDS)	Intracerebral Hemorrhage	01/28	01/28
Kermer, Pawel
No trials found
Zeller, Julia
No trials found